Nothing Special   »   [go: up one dir, main page]

Fung et al., 2013 - Google Patents

Stored blood transfusion induces transient pulmonary arterial hypertension without impairing coagulation in an ovine model of nontraumatic haemorrhage

Fung et al., 2013

View PDF
Document ID
4983553421350511494
Author
Fung Y
Tung J
Foley S
Simonova G
Thom O
Staib A
Collier J
Dunster K
Solano C
Shekar K
Chew M
Fraser J
Publication year
Publication venue
Vox sanguinis

External Links

Snippet

Background and Objectives Transfusion of blood products in particular older products is associated with patient morbidity. Previously, we demonstrated a higher incidence of acute lung injury in lipopolysaccharide‐treated sheep transfused with stored blood products. As …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII

Similar Documents

Publication Publication Date Title
Fung et al. Stored blood transfusion induces transient pulmonary arterial hypertension without impairing coagulation in an ovine model of nontraumatic haemorrhage
Davidow Transfusion medicine in small animals
Acker et al. Quality assessment of established and emerging blood components for transfusion
Palfi et al. A randomized controlled trial oftransfusion‐related acute lung injury: is plasma from multiparous blood donors dangerous?
García-Roa et al. Red blood cell storage time and transfusion: current practice, concerns and future perspectives
Toy et al. Transfusion-related acute lung injury: definition and review
Johnson et al. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles
Dumas et al. Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients
Callan et al. Transfusion of 28‐day‐old leucoreduced or non‐leucoreduced stored red blood cells induces an inflammatory response in healthy dogs
Spinella et al. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital
Bohonek et al. The use of cryopreserved platelets in the treatment of polytraumatic patients and patients with massive bleeding
Scott et al. 2, 3-Diphosphoglycerate concentrations in autologous salvaged versus stored red blood cells and in surgical patients after transfusion
Simonova et al. A comprehensive ovine model of blood transfusion
Johnson et al. PAS‐G supports platelet reconstitution after cryopreservation in the absence of plasma
Larsson et al. Non‐phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags
Karam et al. Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells
Theusinger et al. Transfusion strategy in multiple trauma patients
Wilsher et al. The effect of storing whole blood at 22° C for up to 24 hours with and without rapid cooling on the quality of red cell concentrates and fresh‐frozen plasma
Backholer et al. A paired comparison of thawed and liquid plasma
Chen et al. Increased complement activation during platelet storage
Sheffield et al. Changes in coagulation factor activity and content of di (2‐ethylhexyl) phthalate in frozen plasma units during refrigerated storage for up to five days after thawing
Beattie et al. Liquid plasma: a solution to optimizing early and balanced plasma resuscitation in massive transfusion
Dogra et al. Comparative analysis of activity of coagulation Factors V and VIII and level of fibrinogen in fresh frozen plasma and frozen plasma
Chadebech et al. Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease
Maniatis et al. Alternatives to blood transfusion in transfusion medicine